Abstract
It is hoped the foregoing may illustrate not only the complexities of drug-enzyme interactions but also the richness of the possibilities for selective interference with enzyme systems by foreign agents. At the present time, most of the successful drugs are developed empirically or through synthesis of congeners of pre-existing successful types. One wishes for a rational approach which would permit the deliberate development of new drugs specifically to affect particular enzymes. There have been many attempts to develop drugs on a rational basis. Perhaps these attempts will be more successful in the near future. But it must be admitted that the total enzyme matrix of the living organism is more complex and subtle than formerly visualized. Although new information concerning enzymes and their sensitivity to inhibition is being obtained at a constantly accelerated rate, each increment of knowledge also shows the goal to be a little further away than it had appeared to be.
PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|